Global Clinical Nutrition Market Overview 2023-2028

The global clinical nutrition market size reached US$ 47.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 78.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2023-2028.

Clinical nutrition is a specialized field of nutrition that aims to optimize health and address medical conditions through the application of scientific knowledge and principles. It encompasses the evaluation, diagnosis, and treatment of nutritional issues, as well as the creation of personalized nutrition strategies to support overall well-being and target specific medical concerns. Taking into account factors such as age, gender, medical background, and specific condition-related requirements, clinical nutrition tailors interventions to meet the unique nutritional needs of each individual. It plays a crucial role in preventing and managing a wide range of diseases, as well as facilitating the recovery and rehabilitation of individuals with medical conditions.

Global Clinical Nutrition Market Trends and Drivers:

The global demand for clinical nutrition is being propelled by several key factors. Firstly, there is a significant increase in the prevalence of chronic conditions, including diabetes, cardiovascular diseases, and cancer, which often necessitate specialized dietary requirements. Additionally, the aging population, who are more susceptible to these diseases, further contributes to this demand. Furthermore, the escalating instances of food allergies and intolerances, such as gluten and lactose intolerance, are driving market growth. The growing trend towards personalized medicine is also playing a positive role in this regard. Moreover, the rising number of preterm births and the corresponding need for clinical nutrition in the field of pediatric medicine are also supporting the expansion of the market.

Global Clinical Nutrition Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc and Reckitt Benckiser Group PLC

The report segmented the market on the basis of region, product, route of administration, application and end user.

Breakup by Product:

• Infant Nutrition
• Parental Nutrition
• Enteral Nutrition

Breakup by Route of Administration:

• Oral
• Enteral
• Parenteral

Breakup by Application:

• Cancer
• Malnutrition
• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Others

Breakup by End User:

• Pediatric
• Adults
• Geriatric

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800